Beihai Gofar Chuanshan Biological Co., Ltd. (SHA:600538)
China
· Delayed Price · Currency is CNY 6.85
-0.05 (-0.72%)
Apr 29, 2026, 3:00 PM CST
SHA:600538 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | 328.24 | 338.3 | 367.06 | 457.25 | 421.98 | Upgrade
|
| Other Revenue | - | 2.16 | 2.09 | 2.44 | 2.73 | Upgrade
|
| Revenue | 328.24 | 340.47 | 369.15 | 459.68 | 424.72 | Upgrade
|
| Revenue Growth (YoY) | -3.59% | -7.77% | -19.69% | 8.23% | 58.65% | Upgrade
|
| Cost of Revenue | 254.49 | 254.68 | 279.46 | 332.98 | 316.59 | Upgrade
|
| Gross Profit | 73.75 | 85.78 | 89.7 | 126.71 | 108.12 | Upgrade
|
| Selling, General & Admin | 87.01 | 86.58 | 90.44 | 85.93 | 83.08 | Upgrade
|
| Research & Development | 7.4 | 8.06 | 12.62 | 8.22 | 9.14 | Upgrade
|
| Other Operating Expenses | 2.47 | 2.95 | 3.33 | 3.17 | 3.67 | Upgrade
|
| Operating Expenses | 96.88 | 101 | 111.05 | 102.18 | 98.71 | Upgrade
|
| Operating Income | -23.13 | -15.21 | -21.35 | 24.53 | 9.42 | Upgrade
|
| Interest Expense | - | -2.34 | -0.37 | -0.51 | -0.53 | Upgrade
|
| Interest & Investment Income | 13.22 | 2.63 | 3.58 | 17.38 | 4 | Upgrade
|
| Currency Exchange Gain (Loss) | - | -0.05 | -0.07 | -0.35 | 0.71 | Upgrade
|
| Other Non Operating Income (Expenses) | -2.88 | -3.23 | -1.59 | -0.51 | 0.1 | Upgrade
|
| EBT Excluding Unusual Items | -12.79 | -18.2 | -19.8 | 40.54 | 13.7 | Upgrade
|
| Impairment of Goodwill | - | -60.21 | -55.43 | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | 0.29 | -11.34 | -2.66 | -0.27 | -0.85 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.01 | -2.71 | -0.08 | 0.07 | -0.02 | Upgrade
|
| Asset Writedown | -72.25 | - | -1.4 | - | -0.41 | Upgrade
|
| Other Unusual Items | - | 0.47 | 1.81 | 1.76 | 3.36 | Upgrade
|
| Pretax Income | -84.76 | -91.98 | -77.57 | 42.11 | 15.79 | Upgrade
|
| Income Tax Expense | 1.86 | -0.07 | 3.59 | 5.46 | 5.86 | Upgrade
|
| Earnings From Continuing Operations | -86.62 | -91.91 | -81.16 | 36.65 | 9.93 | Upgrade
|
| Net Income to Company | -86.62 | -91.91 | -81.16 | 36.65 | 9.93 | Upgrade
|
| Minority Interest in Earnings | -1 | -1.94 | -1.15 | -1.81 | 0.56 | Upgrade
|
| Net Income | -87.62 | -93.85 | -82.31 | 34.84 | 10.49 | Upgrade
|
| Net Income to Common | -87.62 | -93.85 | -82.31 | 34.84 | 10.49 | Upgrade
|
| Net Income Growth | - | - | - | 232.25% | 227.65% | Upgrade
|
| Shares Outstanding (Basic) | 515 | 521 | 514 | 498 | 524 | Upgrade
|
| Shares Outstanding (Diluted) | 515 | 521 | 514 | 498 | 524 | Upgrade
|
| Shares Change (YoY) | -1.15% | 1.35% | 3.35% | -5.07% | 14.68% | Upgrade
|
| EPS (Basic) | -0.17 | -0.18 | -0.16 | 0.07 | 0.02 | Upgrade
|
| EPS (Diluted) | -0.17 | -0.18 | -0.16 | 0.07 | 0.02 | Upgrade
|
| EPS Growth | - | - | - | 250.00% | 185.71% | Upgrade
|
| Free Cash Flow | -19.86 | -8.12 | -28 | -23.51 | -29.63 | Upgrade
|
| Free Cash Flow Per Share | -0.04 | -0.02 | -0.05 | -0.05 | -0.06 | Upgrade
|
| Gross Margin | 22.47% | 25.20% | 24.30% | 27.56% | 25.46% | Upgrade
|
| Operating Margin | -7.05% | -4.47% | -5.79% | 5.34% | 2.22% | Upgrade
|
| Profit Margin | -26.69% | -27.57% | -22.30% | 7.58% | 2.47% | Upgrade
|
| Free Cash Flow Margin | -6.05% | -2.38% | -7.58% | -5.11% | -6.98% | Upgrade
|
| EBITDA | -9.33 | -1.85 | -7.47 | 37.55 | 22.44 | Upgrade
|
| EBITDA Margin | -2.84% | -0.54% | -2.02% | 8.17% | 5.28% | Upgrade
|
| D&A For EBITDA | 13.8 | 13.36 | 13.88 | 13.02 | 13.02 | Upgrade
|
| EBIT | -23.13 | -15.21 | -21.35 | 24.53 | 9.42 | Upgrade
|
| EBIT Margin | -7.05% | -4.47% | -5.79% | 5.34% | 2.22% | Upgrade
|
| Effective Tax Rate | - | - | - | 12.97% | 37.13% | Upgrade
|
| Revenue as Reported | - | 340.47 | 369.15 | 459.68 | 424.72 | Upgrade
|
| Advertising Expenses | - | 2.97 | 2.2 | 1.04 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.